Radioactive material used in hospitals detected in sewage water RIVM has, for the first time, investigated the possibility of detecting radioactive substances in sewage. This appears to be the case, as RIVM has found iodine-131 and lutetium-177. Hospitals use these substances in the treatment of patients.
Remove ticks quickly, reduce your risk of Lyme disease Ticks are active again, as shown by the increase in tick bite reports on Tekenradar.nl. Quick action is important: the faster you remove a tick after it bites you, the lower your risk of contracting Lyme disease.
New standard for exposure assessment of cleaning products RIVM has updated the standard for exposure assessment of cleaning products in the ConsExpo Cleaning Products Fact Sheet.
Off-label use of medicines: Room for improvement Medicinal products may be prescribed for other diseases, or groups of patients, than the ones that they are approved for.
The Circular Economy: starting progress measurement in the Netherlands A new report by Statistics Netherlands (CBS), the Netherlands Environmental Assessment Agency (PBL) and RIVM outlines a draft monitoring system to measure progress throughout the planned trans
Scientific article one of the most-read articles of International Water Association (IWA) Publishing With over 1,600 downloads, the scientific article 'Towards a research agenda for water, sanitation and antimicrobial resistance', was one of the most-read articles of IWA Publishing in 2017.
Recommendations for improving groundwater quality assessment Often potentially harmful chemical compounds are present in groundwater. RIVM presents a number of options for the revision of the groundwater quality assessment framework.
Citizen science network produces accurate maps of fine air particles Measurements by thousands of citizen scientists in the Netherlands using their smartphones and the iSPEX add-on are delivering accurate data on fine air particles in the atmosphere that add valuabl
Sustainability of EU regulatory system on medicinal products In safeguarding the quality, safety and efficacy of medicinal products, the present EU regulatory system has become a time consuming and highly regulated process.